Genomma Lab Internacional Sab De Cv operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Genomma Lab Internacional Sab De Cv with three other
pharmaceutical manufacturers in Latin America:
sales of 3.64 billion Brazilian Reals [US$871.70 million]
Diagnosticos Da America SA
(3.40 billion Brazilian Reals [US$814.41 million]
of which 100%
was servi os auxiliares), and
based in Brazil
(2.38 billion Brazilian Reals [US$570.92 million]
of which 84%
was Diagnostic Medicine).
During the year ended December of 2017, sales at
Genomma Lab Internacional Sab De Cv were 12.08 billion Mexican Pesos (US$639.43 million).
increase of 6.7%
versus 2016, when the company's sales were 11.32 billion Mexican Pesos.
Sales of International saw an increase
10.3% in 2017, from
6.63 billion Mexican Pesos to 7.31 billion Mexican Pesos.